| Market Cap | ₹871Cr |
| ROE | 14.04% |
| P/E Ratio(TTM) | 39.60 |
| EPS(TTM) | 26.62 |
| P/B Ratio | 5.68 |
| Dividend Yield | 0.19% |
| Industry P/E | 34.63 |
| Book Value | 185.64 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Parent Organisation | Titan Biotech Limited |
| Managing Director | Mr. Naresh Singla |
| BSE Symbol | 524717 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 75.76 | ||
| Anthem Biosciences | NA (0.00%) | 88.36 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1687.77 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.74 |